Real-world impact of the introduction of chemo-immunotherapy in extended small cell lung cancer: a multicentric analysis

Real-world impact of the introduction of chemo-immunotherapy in extended small cell lung cancer: a multicentric analysis

BackgroundRecent clinical trials demonstrated longer survival in extended small cell lung cancer (SCLC) patients treated with immunotherapy in addition to chemotherapy. However, the magnitude of benefit is modest and the impact in real-world setting has to be fully established.MethodsWe collected cl...

Full description

Bibliographic Details
Main Authors: Laura Bonanno, Lorenzo Calvetti, Alessandro Dal Maso, Alberto Pavan, Loc Carlo Bao, Mattia De Nuzzo, Stefano Frega, Giulia Sartori, Alessandra Ferro, Giulia Pasello, Paolo Morandi, Giuseppe Aprile, Valentina Guarneri
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Immunology
Subjects:
small cell lung cancer
immune-checkpoint inhibitors
frail population
long-term clinical benefit
immune-related toxicity
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1353889/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2024.1353889/full

Similar Items